open access

Vol 94, No 9 (2023)
Research paper
Published online: 2022-04-05
Get Citation

Comparison of the efficacy of pharmacological and nonpharmacological treatments in women with primary dysmenorrhea: randomized controlled parallel-group study

Gizem Boztaş Elverişli1, Nurcan Armağan2, Esra Atilgan3
·
Pubmed: 35419791
·
Ginekol Pol 2023;94(9):687-697.
Affiliations
  1. Department of Physiotherapy and Rehabilitation, Health Sciences Institute, Istanbul Medipol University, Istanbul, Türkiye, Türkiye
  2. Midwifery Department, Faculty of Health Sciences, Istanbul Medipol University, Istanbul, Türkiye, Türkiye
  3. Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Istanbul Medipol University, Istanbul, Türkiye, Türkiye

open access

Vol 94, No 9 (2023)
ORIGINAL PAPERS Gynecology
Published online: 2022-04-05

Abstract

Objectives: To compare the effectiveness of pharmacological (PT) and nonpharmacological treatments (NPT) in women with primary dysmenorrhea (PD) and determine the most effective treatment method. Material and methods: We enrolled 85 PD participants with PD who were randomly classified into five groups: pharmacological groups; naproxen sodium (NS) and micronized purified flavanoid fraction (MPFF), nonpharmacological groups; motor imagery focused pelvic floor exercise (MOPEXE) and acupressure, and no treatment group; control. Initial assessment was conducted in all groups on the first day of the menstrual cycle. After the end of the third menstrual cycle, the specialist physiotherapist and the obstetrician conducted a final evaluation. Intensity and nature of pain were evaluated with the Short-Form McGill Pain Questionnaire (SF-MPQ), and menstrual attitudes and behaviors were evaluated using the Menstruation Attitude Questionnaire (MAQ). Results: In the total pain dimension scores, which are the sum of the affective dimension of pain and sensory dimension scores, the pre–post treatment difference was the highest in the mean of the total pain dimension. The highest was for MOPEXE (15.12 ± 4.44), followed by MPFF (7.53 ± 6.8); acupressure (7.47 ± 5.28) and NS (4.47 ± 4.91) showed more significant change than the control group (p = 0.001). The mean difference in visual analog scale (VAS) scores was highest in MOPEXE (4.53 ± 1.5), followed by acupressure (2.35 ± 1.66); MPFF (1.88 ± 1.73) and NS (1.65 ± 1.84) scores were more significant than the control group (p = 0.001). Regarding total pain intensity, the highest was MOPEXE (2.59 ± 0.94), followed by MPFF (1.18 ± 0.88); acupressure (1.06 ± 0.83) and NS (0.82 ± 1.01) scores were more significant compared to the control group (p = 0.001). There was no significant change in the pre–post difference values in the MAQ subparameters: menstruation as deliberate event, menstruating as bothersome event, menstruation as natural event, anticipation and prediction of the onset of menstruation, and denial of any effects of menstruation; menstruation as a natural event resulted in insignificant changes in parameters (p = 0.579, p = 0.074, p = 0.892, p = 0.056, p = 0. 377). Conclusions: PT and NPT methods in the study were effective in coping with PD-associated pain. MPFF was more effective than the NS group in terms of relieving pain. In terms of pain, MOPEXE and acupressure groups were as effective as PT. The most effective of these treatment methods was the MOPEXE group created by the researcher.

Abstract

Objectives: To compare the effectiveness of pharmacological (PT) and nonpharmacological treatments (NPT) in women with primary dysmenorrhea (PD) and determine the most effective treatment method. Material and methods: We enrolled 85 PD participants with PD who were randomly classified into five groups: pharmacological groups; naproxen sodium (NS) and micronized purified flavanoid fraction (MPFF), nonpharmacological groups; motor imagery focused pelvic floor exercise (MOPEXE) and acupressure, and no treatment group; control. Initial assessment was conducted in all groups on the first day of the menstrual cycle. After the end of the third menstrual cycle, the specialist physiotherapist and the obstetrician conducted a final evaluation. Intensity and nature of pain were evaluated with the Short-Form McGill Pain Questionnaire (SF-MPQ), and menstrual attitudes and behaviors were evaluated using the Menstruation Attitude Questionnaire (MAQ). Results: In the total pain dimension scores, which are the sum of the affective dimension of pain and sensory dimension scores, the pre–post treatment difference was the highest in the mean of the total pain dimension. The highest was for MOPEXE (15.12 ± 4.44), followed by MPFF (7.53 ± 6.8); acupressure (7.47 ± 5.28) and NS (4.47 ± 4.91) showed more significant change than the control group (p = 0.001). The mean difference in visual analog scale (VAS) scores was highest in MOPEXE (4.53 ± 1.5), followed by acupressure (2.35 ± 1.66); MPFF (1.88 ± 1.73) and NS (1.65 ± 1.84) scores were more significant than the control group (p = 0.001). Regarding total pain intensity, the highest was MOPEXE (2.59 ± 0.94), followed by MPFF (1.18 ± 0.88); acupressure (1.06 ± 0.83) and NS (0.82 ± 1.01) scores were more significant compared to the control group (p = 0.001). There was no significant change in the pre–post difference values in the MAQ subparameters: menstruation as deliberate event, menstruating as bothersome event, menstruation as natural event, anticipation and prediction of the onset of menstruation, and denial of any effects of menstruation; menstruation as a natural event resulted in insignificant changes in parameters (p = 0.579, p = 0.074, p = 0.892, p = 0.056, p = 0. 377). Conclusions: PT and NPT methods in the study were effective in coping with PD-associated pain. MPFF was more effective than the NS group in terms of relieving pain. In terms of pain, MOPEXE and acupressure groups were as effective as PT. The most effective of these treatment methods was the MOPEXE group created by the researcher.

Get Citation

Keywords

acupressure; drug therapy; dysmenorrhea; exercise

About this article
Title

Comparison of the efficacy of pharmacological and nonpharmacological treatments in women with primary dysmenorrhea: randomized controlled parallel-group study

Journal

Ginekologia Polska

Issue

Vol 94, No 9 (2023)

Article type

Research paper

Pages

687-697

Published online

2022-04-05

Page views

1604

Article views/downloads

1159

DOI

10.5603/GP.a2022.0009

Pubmed

35419791

Bibliographic record

Ginekol Pol 2023;94(9):687-697.

Keywords

acupressure
drug therapy
dysmenorrhea
exercise

Authors

Gizem Boztaş Elverişli
Nurcan Armağan
Esra Atilgan

References (33)
  1. Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev. 2014; 36: 104–113.
  2. Latthe PM, Champaneria R. Dysmenorrhoea. BMJ Clin Evid. 2014: 813.
  3. Oladosu FA, Tu FF, Hellman KM. Nonsteroidal antiinflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment. Am J Obstet Gynecol. 2018; 218(4): 390–400.
  4. Mukherjee GG, Gajaraj AJ, Mathias J, et al. Treatment of abnormal uterine bleeding with micronized flavonoids. Int J Gynaecol Obstet. 2005; 89(2): 156–157.
  5. Aboualsoltani F, Bastani P, Khodaie L, et al. Non-pharmacological treatments of primary dysmenorrhea: a systematic review. Arch Pharma Pract. 2020; 11(S1): 136–142.
  6. Bavil DA, Dolatian M, Mahmoodi Z, et al. Comparison of lifestyles of young women with and without primary dysmenorrhea. Electron Physician. 2016; 8(3): 2107–2114.
  7. Pattanittum P, Kunyanone N, Brown J, et al. Dietary supplements for dysmenorrhoea. Cochrane Database Syst Rev. 2016; 3: CD002124.
  8. López-Liria R, Torres-Álamo L, Vega-Ramírez FA, et al. Efficacy of physiotherapy treatment in primary dysmenorrhea: a systematic review and meta-analysis. Int J Environ Res Public Health. 2021; 18(15): 7832.
  9. Ferries-Rowe E, Corey E, Archer JS. Primary dysmenorrhea: diagnosis and therapy. Obstet Gynecol. 2020; 136(5): 1047–1058.
  10. Sharghi M, Mansurkhani SM, Larky DA, et al. An update and systematic review on the treatment of primary dysmenorrhea. JBRA Assist Reprod. 2019; 23(1): 51–57.
  11. Carroquino-Garcia P, Jiménez-Rejano JJ, Medrano-Sanchez E, et al. Therapeutic exercise in the treatment of primary dysmenorrhea: a systematic review and meta-analysis. Phys Ther. 2019; 99(10): 1371–1380.
  12. Beuscher-Willems B. Female genital tract. In: Schmidt G. ed. Differential diagnosis in ultrasound imaging: A teaching atlas. Thieme Medical Publishers, New York 2006: 389–404.
  13. Marjoribanks J, Ayeleke RO, Farquhar C, et al. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2015(7): CD001751.
  14. Pascarella L. Essentials of daflon 500 mg: from early valve protection to long-term benefits in the management of chronic venous disease. Curr Pharm Des. 2007; 13(4): 431–444.
  15. Lyseng-Williamson KA, Perry CM. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs. 2003; 63(1): 71–100.
  16. Mehta P, Dhapte V, Kadam S, et al. Contemporary acupressure therapy: adroit cure for painless recovery of therapeutic ailments. J Tradit Complement Med. 2017; 7(2): 251–263.
  17. Yu S, Yang J, Yang M, et al. Application of acupoints and meridians for the treatment of primary dysmenorrhea: a data mining-based literature study. Evid Based Complement Alternat Med. 2015; 2015: 752194.
  18. Bazarganipour F, Taghavi SA, Allan H, et al. A randomized controlled clinical trial evaluating quality of life when using a simple acupressure protocol in women with primary dysmenorrhea. Complement Ther Med. 2017; 34: 10–15.
  19. Yakut Y, Yakut E, Bayar K, et al. Reliability and validity of the Turkish version short-form McGill pain questionnaire in patients with rheumatoid arthritis. Clin Rheumatol. 2007; 26(7): 1083–1087.
  20. Kulakaç Ö, Oncel S, Firat MZ, et al. Menstrual attitude questionnaire: validity and reliability study. Turkiye Klinikleri J Gynecol Obst. 2008; 18(6): 347–356.
  21. Daniels SE, Paredes-Diaz A, An R, et al. Significant, long-lasting pain relief in primary dysmenorrhea with low-dose naproxen sodium compared with acetaminophen: a double-blind, randomized, single-dose, crossover study. Curr Med Res Opin. 2019; 35(12): 2139–2147.
  22. Ortiz MI, Murguía-Cánovas G, Vargas-López LC, et al. Naproxen, paracetamol and pamabrom versus paracetamol, pyrilamine and pamabrom in primary dysmenorrhea: a randomized, double-blind clinical trial. Medwave. 2016; 16(9): e6587.
  23. Motahari-Tabari N, Shirvani MA, Alipour A. Comparison of the effect of stretching exercises and mefenamic acid on the reduction of pain and menstruation characteristics in primary dysmenorrhea: a randomized clinical trial. Oman Med J. 2017; 32(1): 47–53.
  24. Shirvani MA, Motahari-Tabari N, Alipour A. The effect of mefenamic acid and ginger on pain relief in primary dysmenorrhea: a randomized clinical trial. Arch Gynecol Obstet. 2015; 291(6): 1277–1281.
  25. Blödt S, Pach D, Eisenhart-Rothe Sv, et al. Effectiveness of app-based self-acupressure for women with menstrual pain compared to usual care: a randomized pragmatic trial. Am J Obstet Gynecol. 2018; 218(2): 227.e1–227.e9.
  26. Guillot A, Moschberger K, Collet C. Coupling movement with imagery as a new perspective for motor imagery practice. Behav Brain Funct. 2013; 9: 8.
  27. Fusco A, Iosa M, Gallotta MC, et al. Different performances in static and dynamic imagery and real locomotion. An exploratory trial. Front Hum Neurosci. 2014; 8: 760.
  28. Moawed MA, Salem NA, Elbalawy YM. Effect of motor imagery training on urinary incontinence in patients with incomplete spinal cord injury. Med J Cairo Univ. 2020; 88(3): 869–873.
  29. Kannan P, Claydon LS. Some physiotherapy treatments may relieve menstrual pain in women with primary dysmenorrhea: a systematic review. J Physiother. 2014; 60(1): 13–21.
  30. Corral-Moreno V, Munuera-Jiménez FJ, Cascos-Vicente L, et al. Tratamiento fisioterapéutico para la dismenorrea primaria: una revisión sistemática. Fisioterapia. 2022; 44(1): 43–50.
  31. Armour M, Parry K, Manohar N, et al. The prevalence and academic impact of dysmenorrhea in 21,573 young women: a systematic review and meta-analysis. J Womens Health (Larchmt). 2019; 28(8): 1161–1171.
  32. Selçuk A, Yanikkerem E. Effect of acupressure on primary dysmenorrhea: review of experimental studies. J Acupunct Meridian Stud. 2021; 14(2): 33–49.
  33. Jiang HR, Ni S, Li JL, et al. Systematic review of randomized clinical trials of acupressure therapy for primary dysmenorrhea. Evid Based Complement Alternat Med. 2013; 2013: 169692.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl